Biocon Ltd announced Tuesday that its unit Biocon Biologics oncology biosimilars will expand with three new cancer therapies aimed at strengthening its presence in the global oncology market. With a regulatory filing, the company announced that...
Lupin Ltd announced today that its subsidiary, Lupin Manufacturing Solutions has entered into a longterm agreement with PolyPeptide Group AG. The joint venture will strengthen the global peptide-based active pharmaceutical ingredients supply...
Sun Pharmaceutical Industries has secured a major win after the Ahmedabad bench of the Customs, Excise and Service Tax Appellate Tribunal granted Sun Pharma CESTAT relief by setting aside a Rs 39 crore excise duty demand raised by tax authorities...
Eli Lilly has entered into a huge collaboration with Nimbus Therapeutics to develop a new obesity pill. This action assists Lilly in its quest to get out of injectable weight-loss drugs. The transaction, which was announced today, is aimed at...
.jpeg "Dr Reddy's Launches Hevaxin Hepatitis E Vaccine In India")
Dr Reddy’s launches Hevaxin, India’s only DCGI-approved hepatitis E vaccine, offering long-term immunity and supporting national efforts to reduce liver disease burden.
The 3rd Edition of Pack.Nxt successfully concluded on 16 December 2025 at The Lalit, Mumbai, bringing together senior packaging leaders, brand owners, converters, policymakers, consultants, and technology enablers for a full day of honest conversatio
Wegovy pill is now available in the U.S., bringing proven GLP 1 weight loss science into a simple once daily tablet. Approved on December 22, 2025, this new option expands treatment choices for more than 100 million Americans living with obesity...
Jaguar Health today announced it has secured a $240,000 FDA grant to advance research on a treatment for chemotherapy-induced diarrhea in dogs, a serious and often dangerous side effect of cancer care...
AstraZeneca today announced positive phase III clinical data for baxdrostat, an investigational oral therapy being developed for patients with uncontrolled or resistant hypertension. The results strengthen baxdrostat’s position as a potential...
Torrent Pharma approves Rs 12,500 crore NCD issue to boost liquidity, fund acquisitions and capex, while maintaining strong balance sheet, low leverage, and long-term growth focus.
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")